Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Bio-Uv Group | 4Y4 | 31. oct 2024 | 1.91 | -0.10 |
Bio-Works Technologies | 1BD | 31. oct 2024 | 0.05 | -8.28 |
BioArctic B | B9A | 31. oct 2024 | 12.94 | -4.01 |
BioCardia, Inc. | 6JU | 31. oct 2024 | 4.26 | 0.00 |
BIOCELTIX S.A. | XI3 | 31. oct 2024 | 14.76 | -0.54 |
BioCryst Pharmaceuticals, Inc. | BO1 | 31. oct 2024 | 7.38 | -2.79 |
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. | I54 | 31. oct 2024 | 0.65 | -22.75 |
Bioera S.P.A | B2A | 31. oct 2024 | 0.05 | -0.81 |
Bioextrax | 85X0 | 31. oct 2024 | 0.26 | -0.57 |
BioFish Holding AS | 9R2 | 31. oct 2024 | 0.04 | 0.00 |
Biofrontera AG | B8FK | 31. oct 2024 | 3.00 | +3.99 |
BIOGAIA AB B O.N. | BGLA | 31. oct 2024 | 9.12 | -0.98 |
Biogen Inc. | IDP | 31. oct 2024 | 161.85 | -3.60 |
BioHarvest Sciences | 8MV0 | 31. oct 2024 | 4.07 | -0.12 |
BioInvent International | BIX0 | 31. oct 2024 | 3.81 | -4.16 |
BioLife Solutions, Inc. | BJX1 | 31. oct 2024 | 21.80 | 0.00 |
BioLineRx Ltd. - American Depositary Shares | YP2A | 31. oct 2024 | 0.34 | -5.03 |
BioMarin Pharmaceutical Inc. | BM8 | 31. oct 2024 | 60.76 | -2.47 |
BioMark Diagnostics Inc | 20B | 31. oct 2024 | 0.14 | -0.71 |
Biomaxima SA | 944 | 31. oct 2024 | 2.85 | -3.06 |
Biome Grow Inc | 6OTA | 31. oct 2024 | 0.00 | 0.00 |
Biomed-Lubin Wytwornia Surowic I Szczepionek S.A. | 6NQ | 31. oct 2024 | 0.93 | -0.43 |
Biomerieux | EYWN | 31. oct 2024 | 102.90 | -4.72 |
Biomind Labs Inc | 3XI | 31. oct 2024 | 0.22 | 0.00 |
Bionomics ADR | B1N0 | 31. oct 2024 | 0.08 | -17.77 |
BioNTech SE - American Depositary Shares | 22UA | 31. oct 2024 | 104.90 | +0.48 |
BIONXT SOLUTIONS INC. | BXT | 31. oct 2024 | 0.16 | 0.00 |
BioPharma Credit Plc | B3P | 31. oct 2024 | 0.76 | -9.04 |
Biophytis | 6XB | 31. oct 2024 | 0.00 | 0.00 |
BIOPHYTIS NAM. EO -,80 | 6XB3 | 31. oct 2024 | 0.30 | +4.70 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.